No evidence for toxicity after long-term photobiomodulation in normal non-human primates
Description | |
Date | |
Authors | Moro C., Torres N., Arvanitakis K., Cullen K., Chabrol C., Agay D., Darlot F., Benabid A.-L., Mitrofanis J. |
Year | 2017-0462 |
Source-Title | Experimental Brain Research |
Affiliations | University of Grenoble Alpes, CEA, LETI, CLINATEC, MINATEC Campus, Grenoble, France, Department of Anatomy F13, University of Sydney, Camperdown, Australia |
Abstract | In this study, we explored the effects of a longer term application, up to 12 weeks, of photobiomodulation in normal, naïve macaque monkeys. Monkeys (n = 5) were implanted intracranially with an optical fibre device delivering photobiomodulation (red light, 670 nm) to a midline midbrain region. Animals were then aldehyde-fixed and their brains were processed for immunohistochemistry. In general, our results showed that longer term intracranial application of photobiomodulation had no adverse effects on the surrounding brain parenchyma or on the nearby dopaminergic cell system. We found no evidence for photobiomodulation generating an inflammatory glial response or neuronal degeneration near the implant site, further, photobiomodulation did not induce an abnormal activation or mitochondrial stress in nearby cells, nor did it cause an abnormal arrangement of the surrounding vasculature (endothelial basement membrane). Finally, because of our interest in Parkinson’s disease, we noted that photobiomodulation had no impact on the number of midbrain dopaminergic cells and the density of their terminations in the striatum. In summary, we found no histological basis for any major biosafety concerns associated with photobiomodulation delivered by our intracranial approach and our findings set a key template for progress onto clinical trial on patients with Parkinson’s disease. © 2017, Springer-Verlag GmbH Germany. |
Author-Keywords | 670 nm, Behaviour, Macaque monkeys, Striatum, Substantia nigra, Tyrosine hydroxylase |
Index-Keywords | chaperonin 60, glial fibrillary acidic protein, IBA1 protein, protein, protein fos, unclassified drug, adult, animal cell, animal tissue, antibody labeling, Article, basement membrane, cell damage, controlled study, corpus striatum, cytoarchitecture, endothelial basement membrane, immunohistochemistry, immunoreactivity, low level laser therapy, Macaca fascicularis, mesencephalon, microglia, nerve cell degeneration, Nissl staining, nonhuman, nuclear magnetic resonance imaging, parenchyma, Parkinson disease, photobiomodulation, priority journal, silver impregnation, thalamus |
ISSN | 144819 |
Link | Link |